Cleveland Clinic:
Science Internship Program
The Science Internship Program is a nine-week summer internship that, through hands-on learning opportunities, gives rising high school juniors and seniors the opportunity to work and learn alongside Cleveland Clinic caregivers in a variety of clinical fields and careers within healthcare(as providers and researchers) including medicine, nursing, laboratory medicine, physical therapy, public health, radiology, respiratory care and creative learning.
Internship Year: 2016
Abstract: Restrictive eating disorders (EDs) have severe effects on both the mental and physical health of a patient, including bone health. With many eating disorders beginning in adolescence, these youth may have greater risk of osteopenia if proper weight restoration does not occur. Recovery occurs when the patient achieves growth along the curve expected by their bone structure. Determining bone structure may be very useful in predicting an optimal growth curve for a given patient. Little data currently exists on whether this method accurately helps determine the utility of this method for predicting weight and growth recovery across all bone structures.
Internship Year: 2017
Abstract: Sickle cell disease is a blood disorder caused by sickle hemoglobin located in the red blood cells. Newborn screenings are used to diagnose developmental, metabolic, and genetic disorders, including sickle cell disease. These screenings are important because they allow proper care before symptoms occur and in regards to sickle cell, allows patients and their families to learn and receive support about the disease. Our hypothesis was that newborn screenings would allow patients with sickle cell time to manage the disease and get earlier treatment in order to prevent further complications.
Internship Year: 2018
Abstract: Sickle cell disease is a blood disorder caused by sickled hemoglobin located in the red blood cells. Due to many factors, the transition from pediatric care to adult care for young adults with sickle cell disease tends to be a difficult one. Although there is no widespread cure for sickle cell, developing a strong, productive transition plan for these patients may help them live longer and more productive lives.